Michael Fare
Chief Operating Officer at AdipoPharma SAS
- Role
- Chief Operating Officer at Adipopharma Sas
- Location
- Guilford, CT, US
- LinkedIn followers
- 500 followers
About Michael Fare
Experienced pharmaceutical executive with background in drug discovery research and development and “hands on” responsibility for project management, client relationships, and business development. Mr. Fare was a founding member of The Institutes for Pharmaceutical Discovery, LLC. Responsibilities at Wyeth-Ayerst included the international marketing of oral and barrier contraceptives and nonsteroidal anti-inflammatory drugs; business development and new product marketing; and market research. Experienced with international contract negotiations, financial analysis, long-range global strategic planning, and marketing/regulatory strategies.
Experience
Chief Operating Officer
Jan 2023 — Present · Strasbourg, FR
Education
Drexel University
M.S., Technical and Science Communication
1981 — 1984
Saint Joseph's University
Bachelor of Arts - BA, Politics
Skills
- Project Management
- Product Launch
- Chemistry
- Immunology
- Market Analysis
- Pharmaceutical Sales
- Pharmaceutics
- Drug Discovery
- Vaccines
- Infectious Diseases
- Life Sciences
- Oncology
- Molecular Biology
- CRO
- Commercialization
- Drug Development
- Cancer
- Gcp
- Biopharmaceuticals
- Intellectual Property
- Regulatory Submissions
- Leadership
- Strategic Planning
- Market Research
- Competitive Analysis
- Product Development
- Technology Transfer
- Clinical Trials
- Business Development
- Medical Devices
- Glp
- Strategy
- Diabetes
- Validation
- Gmp
- Therapeutic Areas
- Pharmacology
- Cell Culture
- Ctms
- Regulatory Affairs
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.